October 18-20 | Tucson, AZ

The Research Institution GAP Fund and Accelerator Program Summit

U Texas Decisio Health introduces clinical platform, draws $4.5M in Series B round

Get our GAP Insights Newsletter

Join Upcoming Events

October 18-20, 2023 / Tucson, AZ
The annual summit for research institution gap fund and accelerator programs, including proof of concept programs, startup accelerators, and university venture funds

The Story

Decisio Health, a startup that aims to help acute-care provider organizations continually improve their clinical processes, launched the Decisio Health Clinical Intelligence Platform Tuesday and also announced $4.5M in Series B funding, topping the $2.5M it garnered in its over-subscribed Series A.

This most recent round was led by DECLATEX, LLC with participation by the University of Texas Horizon Fund. The company also added Larry Lawson, founder of eCardio, as an investor and board member.

Based on technology developed at the University of Texas Health Center, Decisio executives describe the Decisio Clinical Intelligence Platform as an FDA 501(k)-cleared Class II medical device that gathers and interprets data from existing hospital monitoring systems to provide the most current and valuable information in one easy-to-view location – at the bedside.

It provides clinical decision support, showing vital trends and lab snapshots giving care teams immediate access to the data they need to treat their patients. It also digitizes and displays a hospital’s own protocols for diagnosis and treatment. The goal is to reduce variability of care, which can lead to better patient outcomes.

“The Clinical Intelligence Platform was created for clinicians, by clinicians with a focus on providing real-time relevant data at the point of care,” said Decisio Health CEO Bryan Haardt in a statement. “By arming clinicians with this information they are able to be more patient-focused and proactive in their decision-making via simple, visual and instantaneous access to the most critical patient data and trends.”

“Decisio Health is a perfect example of an ambitious startup that’s taking a remarkable technology developed by UT Health Science Center at Houston researchers into a commercially viable enterprise determined to change the healthcare landscape,” said Julie Goonewardene,  in a statement.

Goonewardene is UT System associate vice chancellor for innovation and strategic investment and managing director of the UT Horizon Fund.

Decisio Health is one of 17 startups that have been funded by the UT Horizon Fund, a formative-stage venture fund that provides capital and support to companies with tangible ties to one of UT System’s 14 academic and health institutions.

Source: Decisio Health introduces clinical platform, draws $4.5M in Series B round | Healthcare IT News

Get the Report

More GAP News